
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
β8 Tubulin CRISPR/Cas9 KO Plasmid (h) | sc-401438 | 20 µg | $397.00 |
TUBB8 encodes β8 tubulin, a β-tubulin isotype that polymerizes with α-tubulin to form microtubules, supporting cytoskeletal architecture, intracellular transport, and spindle dynamics during cell division. Microtubule remodeling underlies processes such as mitosis, organelle positioning, and cell polarity through coordinated regulation by microtubule-associated proteins and post-translational tubulin modifications. Altered tubulin isotype composition can influence microtubule stability and sensitivity to microtubule-targeting stress, linking tubulin biology to defects in chromosome segregation and cellular homeostasis. TUBB8 has been studied in the context of reproductive and developmental phenotypes where microtubule organization is critical, providing a model for dissecting isotype-specific contributions to microtubule function.
β8 Tubulin CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the TUBB8 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the TUBB8 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the TUBB8 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish β8 Tubulin protein expression.
This CRISPR knockout system enables efficient generation of TUBB8-deficient cell models for investigation of β8 Tubulin signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.